合成医薬品の最適化と安定性予測のためのAI駆動のウェブプラットフォーム
Artur Grigoryan1, Stefan Helfrich2, Valentin Lequeux1
1Fripharm®, Pharmacy Department, Groupe Hospitalier Centre Edouard Herriot, Hospices Civils de Lyon, 5, Place d'Arsonval, F-69437 Lyon, France.
Pharmaceuticals (Basel, Switzerland)
|August 28, 2025
まとめ
AIプラットフォームであるスマート・フォーミュレーションは,複合薬の使用期限を超えた (BUD) 状態を予測しています. 薬剤師が 薬の安定性を最適化するために 分子,配方,環境要因を考慮し 患者のケアを改善します
科学分野:
- コンピューター製薬
- 薬剤の製造における人工知能
- 薬剤の安定性を予測するモデリング
背景:
- 口服用固体用薬は,正確な使用日 (Beyond Use Dates,BUD) を要求する.
- BUDを決定する現在の方法は,時間がかかり,費用がかかります.
- 患者の安全のために,即効薬の安定性を最適化することが重要です.
研究 の 目的:
- BUDを予測するためのAIベースの意思決定支援ツール"Smart Formulation"を開発する.
- 安定性予測のための分子,配方,環境パラメータを統合する.
- 薬剤師が複合薬の安定性を最適化するのに役立つ.
主な方法:
- 55の実験BUD値でツリーアンサンブル回帰モデルを訓練した.
- 配列は分子記述子,補助物質の組成,包装,保存条件でコード化されました.
- このモデルは,化学情報学と機械学習の統合のためのKNIMEプラットフォームを使用して実装されました.
主要な成果:
- 補助物質の種類,数量,環境条件はAPIの安定性に大きく影響する.
- LogP値の低下と単一のエキシピエンツ (例えば,セルロース,シリカ,サクロース,マニトール) は,より高い安定性に相関する.
- 乳糖とHPMCは分解を加速し,2つのエキシピエントを使用すると,しばしばBUDが減少します.
結論:
- スマート・フォーミュレーションは,製薬業界にとって貴重な計算ツールであり,配方設計と複合剤のニーズを結びつけています.
- このプラットフォームは,従来の安定性テストに代わって,スケーラブルで費用対効果の高い代替手段を提供します.
- 薬の不足を軽減し 製剤を標準化し 患者のケアを向上させることができます
関連する概念動画
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
124
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
124
Pharmacokinetic Models: Comparison and Selection Criterion
147
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
147
Pharmacokinetic Models: Overview
1.1K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.1K
Model Approaches for Pharmacokinetic Data: Compartment Models
198
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
198
Analysis of Population Pharmacokinetic Data
382
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
382
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
223
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
223


